Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

NCT01825824 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

RADIATION: Stereotactic ablative radiotherapy

Sponsor

Korea Cancer Center Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]